Evaluating the prognostic significance of preoperative thrombocytosis in epithelial ovarian cancer

Gynecologic Oncology

Volumn 130, Issue 3, 2013, Pages 499-504

  Allensworth, S K ^a   Langstraat, C L ^a   Martin, J R ^a   Lemens, M A ^a   McGree, M E ^a   Weaver, A L ^a   Dowdy, S C ^a   Podratz, K C ^a   Bakkum Gamez, J N ^a  

^a MAYO CLINIC   (United States)

Author keywords

Epithelial ovarian cancer; Paraneoplastic thrombocytosis

Indexed keywords

ALBUMIN; HEMOGLOBIN;

ADULT; AGING; ALBUMIN BLOOD LEVEL; ARTICLE; ASCITES; CANCER MORTALITY; CANCER PATIENT; CANCER PROGNOSIS; CANCER RECURRENCE; CANCER STAGING; CANCER SURGERY; CANCER SURVIVAL; CORONARY ARTERY DISEASE; DEEP VEIN THROMBOSIS; DISEASE ASSOCIATION; DISEASE FREE SURVIVAL; EARLY CANCER; ERYTHROCYTE TRANSFUSION; FEMALE; FOLLOW UP; HEMOGLOBIN BLOOD LEVEL; HOSPITALIZATION; HUMAN; HYSTERECTOMY; INCIDENCE; INTESTINE OBSTRUCTION; LUNG EMBOLISM; MAJOR CLINICAL STUDY; MINIMAL RESIDUAL DISEASE; OVARY CARCINOMA; OVERALL SURVIVAL; POSTOPERATIVE COMPLICATION; POSTOPERATIVE ILEUS; PREOPERATIVE EVALUATION; PRIORITY JOURNAL; RETROSPECTIVE STUDY; SALPINGOOOPHORECTOMY; SURGICAL INFECTION; THROMBOCYTE COUNT; THROMBOCYTOSIS; URINARY TRACT INFECTION;

EPITHELIAL OVARIAN CANCER; PARANEOPLASTIC THROMBOCYTOSIS;

DISEASE-FREE SURVIVAL; FEMALE; HUMANS; NEOPLASM RECURRENCE, LOCAL; NEOPLASM STAGING; NEOPLASMS, GLANDULAR AND EPITHELIAL; OVARIAN NEOPLASMS; PREOPERATIVE PERIOD; PROGNOSIS; RETROSPECTIVE STUDIES; RISK FACTORS; SURVIVAL RATE; THROMBOCYTOSIS;

EID: 84882455488     PISSN: 00908258     EISSN: 10956859     Source Type: Journal    
DOI: 10.1016/j.ygyno.2013.05.038     Document Type: Article

References (25)

1. R. Siegel, and A. Jemal Cancer statistics CA Cancer J Clin 62 1 2012 10 29
2. R.L. Stone, A.M. Nick, I.A. McNeish, F. Balkwill, H.D. Han, and J. Bottsford-Miller Paraneoplastic thrombocytosis in ovarian cancer N Engl J Med 366 7 2012 610 618
3. T. Gungor, M. Kanat-Pektas, A. Sucak, and L. Mollamahmutoglu The role of thrombocytosis in prognostic evaluation of epithelial ovarian tumors Arch Gynecol Obstet 279 1 2009 53 56
4. J. Wheler, A.M. Tsimberidou, D. Hong, A. Naing, T. Jackson, and S. Liu Survival of patients in a phase 1 clinic Cancer 115 2009 1091 1099
5. D. de Jong, M.J. Eijkemans, S. Lie Fong, C.G. Gerestein, G.S. Kooi, and A. Baalbergen Preoperative predictors for residual tumor after surgery in patients with ovarian carcinoma Oncology 72 5-6 2007 293 301
6. D.L. Richardson, A. Mariani, and W.A. Cliby Risk factors for anastomotic leak after recto-sigmoid resection for ovarian cancer Gynecol Oncol 103 2 2006 667 672
7. T. Herzog Correlation between CA-125 serum level and response to RECIST in a phase III ovarian cancer study Gynecol Oncol 122 2 2011 350 355
8. A. Aminian, F. Karimian, R. Mirsharifi, A. Alibakhshi, H. Dashti, and Y. Jahangiri Significance of platelet count in esophageal carcinomas Saudi J Gastroenterol 17 2 2011 134 137
9. K. Sasaki, K. Kawai, N.H. Tsuno, E. Sunami, and J. Kitayama mpact of preoperative thrombocytosis on the survival of patients with primary colorectal cancer World J Surg 36 1 2012 192 200
10. M.S. Cho, J. Bottsford-Miller, H.G. Vasquez, R. Stone, B. Zand, and M.H. Kroll Platelets increase the proliferation of ovarian cancer cells Blood 120 24 2012 Dec 6 4869 4872
11. A. Radziwon-Balicka, C. Medina, L. O'Driscoll, A. Treumann, D. Bazou, and I. Inkielewicz-Stepniak Platelets increase survival of adenocarcinoma cells challenged with anticancer drugs: mechanisms and implications for chemoresistance Br J Pharmacol 167 4 2012 787 804
12. G.P. Gupta, and J. Massague Platelets and metastasis revisited: a novel fatty link J Clin Invest 114 12 2004 1691 1693
13. C.E. Holmes, J.E. Levis, and D.L. Ornstein Activated platelets enhance ovarian cancer cell invasion in cellular model of metastasis Clin Exp Metastasis 26 7 2009 653 661
14. A.J. Li, and B.Y. Karlan Androgen mediation of thrombocytosis in epithelial ovarian cancer biology Clin Cancer Res 11 22 2005 8015 8018
15. L. Manenti, P.P., I. Floriani, F. Landoni, V. Torri, and A. Buda Expression levels of vascular endothelial growth factor, matrix metalloproteinases 2 and 9 and tissue inhibitor of metalloproteinases 1 and 2 in the plasma of patients with ovarian carcinoma Eur J Cancer 39 13 2003 1948 1956
16. G.D. Aletti, S.C. Dowdy, K.C. Podratz, and W.A. Cliby Relationship among surgical complexity, short-term morbidity, and overall survival in primary surgery for advanced ovarian cancer Am J Obstet Gynecol 197 6 2007 676.e1 676.e7
17. F. Khoury-Collado, and D.S. Chi Recent surgical management of ovarian cancer J Obstet Gynaecol Res 37 5 2011 379 382
18. A.J. Li, A.C. Madden, I.C. Cass, R.S. Leuchter, L.D. Lagasse, and B.Y. Karlan The prognostic significance of thrombocytosis in epithelial ovarian carcinoma Gynecol Oncol 92 1 2004 211 214
19. M. Lee, S.W. Kim, E.J. Nam, G.W. Yim, S. Kim, and Y.T. Kim The impact of pretretament thrombocytosis and persistent thrombocytosis after adjuvant chemotherapy in patients with advanced epithelial ovarian cancer Gynecol Oncol 122 2 2011 238 241
20. A.G. Zeimet, C. Marth, E. Muller-Holzner, G. Daxenbichler, and O. Dapunt Significance of thrombocytosis in patients with epithelial ovarian cancer AJOG 170 2 1994 549 554
21. J.A. Crasta, TS. Premlatha, S.M. Krishnan, E. Vallikad, and K. Rameshkumar Significance of preoperative thrombocytosis in epithelial ovarian cancer Indian J Pathol Microbiol 53 1 2010 54 56
22. G.D. Aletti, S.C. Dowdy, B.S. Gostout, M.B. Jones, C.R. Stanhope, and T.O. Wilson Aggressive surgical effort and improved survival in advanced-stage ovarian cancer Obstet Gynecol 107 1 2006 77 85
23. A. Elattar, A. Bryant, B.A. Winter-Roach, M. Hatem, and R. Naik Optimal primary surgical treatment for advanced epithelial ovarian cancer Cochrane Database Syst Rev 8 2011 CD007565
24. R.F. Ozols, B.N. Bundy, B.E. Greer, J.M. Fowler, D. Clarke-Pearson, and R.A. Burger Phase III trial of carboplatin and paclitaxel compared with cisplatin and paclitaxel in patients with optimally resected stage III ovarian cancer: a gynecologic oncology group study J Clin Oncol 21 17 2003 3194 3200
25. B.E. Storer, T.A. Gooley, and M.P. Jones Adjusted estimates for time-to-event endpoints Lifetime Data Anal 14 4 2008 484 495